The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial
ConclusionSe supplementation as add-on therapy with medical management induced remission and improved the quality of life in patients with active mild-to-moderate UC.Trial registration number and date of registrationIRCT20091114002709N51; 2020-04-13.
Source: European Journal of Nutrition - Category: Nutrition Source Type: research
More News: Clinical Trials | Inflammatory Bowel Disease | Nutrition | Selenium | Study | Ulcerative Colitis